Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 157

1.

[Laryngeal Recurrent Respiratory Papillomatosis: Current Aspects on Diagnosis and Therapy].

Langer C, Wittekindt C, Wolf G.

Laryngorhinootologie. 2019 Aug;98(8):577-587. doi: 10.1055/a-0896-9729. Epub 2019 Aug 6. German.

PMID:
31387134
2.

Impact on survival of tobacco smoking for cases with oropharyngeal squamous cell carcinoma and known human papillomavirus and p16-status: a multicenter retrospective study.

Grønhøj C, Jensen JS, Wagner S, Dehlendorff C, Friborg J, Andersen E, Wittekindt C, Würdemann N, Sharma SJ, Gattenlöhner S, Klussmann JP, von Buchwald C.

Oncotarget. 2019 Jul 23;10(45):4655-4663. doi: 10.18632/oncotarget.27079. eCollection 2019 Jul 23.

3.

Somatic mutations and promotor methylation of the ryanodine receptor 2 is a common event in the pathogenesis of head and neck cancer.

Schmitt K, Molfenter B, Laureano NK, Tawk B, Bieg M, Hostench XP, Weichenhan D, Ullrich ND, Shang V, Richter D, Stögbauer F, Schroeder L, de Bem Prunes B, Visioli F, Rados PV, Jou A, Plath M, Federspil PA, Thierauf J, Döscher J, Weissinger SE, Hoffmann TK, Wagner S, Wittekindt C, Ishaque N, Eils R, Klussmann JP, Holzinger D, Plass C, Abdollahi A, Freier K, Weichert W, Zaoui K, Hess J.

Int J Cancer. 2019 Dec 15;145(12):3299-3310. doi: 10.1002/ijc.32481. Epub 2019 Jun 19.

PMID:
31135957
4.

Genetic alterations in human papillomavirus-associated oropharyngeal squamous cell carcinoma of patients with treatment failure.

Reder H, Wagner S, Gamerdinger U, Sandmann S, Wuerdemann N, Braeuninger A, Dugas M, Gattenloehner S, Klussmann JP, Wittekindt C.

Oral Oncol. 2019 Jun;93:59-65. doi: 10.1016/j.oraloncology.2019.04.013. Epub 2019 Apr 28.

PMID:
31109697
5.

Increasing Incidence rates of Oropharyngeal Squamous Cell Carcinoma in Germany and Significance of Disease Burden Attributed to Human Papillomavirus.

Wittekindt C, Wagner S, Bushnak A, Prigge ES, von Knebel Doeberitz M, Würdemann N, Bernhardt K, Pons-Kühnemann J, Maulbecker-Armstrong C, Klussmann JP.

Cancer Prev Res (Phila). 2019 Jun;12(6):375-382. doi: 10.1158/1940-6207.CAPR-19-0098. Epub 2019 Apr 19.

PMID:
31003993
6.

A systematic review of the HPV-attributable fraction of oropharyngeal squamous cell carcinomas in Germany.

Reuschenbach M, Tinhofer I, Wittekindt C, Wagner S, Klussmann JP.

Cancer Med. 2019 Apr;8(4):1908-1918. doi: 10.1002/cam4.2039. Epub 2019 Mar 1.

7.

[Correction: Value of sialendoscopy in German ENT-hospitals in 2016].

Kroll T, Schwarz D, Stuermer KJ, Wittekindt C, Sharma SJ, Klußmann JP, Wolf G.

Laryngorhinootologie. 2019 Feb;98(2):E1. doi: 10.1055/a-0849-2046. Epub 2019 Feb 8. German. No abstract available.

PMID:
30736058
8.

Risk profiling based on p16 and HPV DNA more accurately predicts location of disease relapse in patients with oropharyngeal squamous cell carcinoma.

Rasmussen JH, Grønhøj C, Håkansson K, Friborg J, Andersen E, Lelkaitis G, Klussmann JP, Wittekindt C, Wagner S, Vogelius IR, von Buchwald C.

Ann Oncol. 2019 Apr 1;30(4):629-636. doi: 10.1093/annonc/mdz010.

PMID:
30657857
9.

Impact of extent of parotidectomy on early and long-term complications: A prospective multicenter cohort trial.

Grosheva M, Pick C, Granitzka T, Sommer B, Wittekindt C, Klussmann JP, Guntinas-Lichius O, Beutner D.

Head Neck. 2019 Jun;41(6):1943-1951. doi: 10.1002/hed.25651. Epub 2019 Jan 11.

PMID:
30633414
10.

[Value of sialendoscopy in German ENT-hospitals in 2016].

Kroll T, Schwarz D, Stürmer K, Sharma SJ, Klußmann JP, Wittekindt C, Wolf G.

Laryngorhinootologie. 2019 Feb;98(2):91-95. doi: 10.1055/a-0805-5846. Epub 2018 Dec 11. German. Erratum in: Laryngorhinootologie. 2019 Feb;98(2):E1.

PMID:
30537772
11.

[HPV-associated oropharyngeal cancer-incidence, trends, diagnosis, and treatment].

Wagner S, Reder H, Sharma SJ, Würdemann N, Wittekindt C, Klußmann JP.

Urologe A. 2018 Dec;57(12):1457-1463. doi: 10.1007/s00120-018-0810-4. Review. German.

PMID:
30421134
12.

[Update on HPV-associated head and neck cancer-highlights of the 2018 ASCO Annual Meeting].

Tribius S, Würdemann N, Laban S, Sharma SJ, Wagner S, Hoffmann TK, Wittekindt C, Klussmann JP.

HNO. 2018 Dec;66(12):888-895. doi: 10.1007/s00106-018-0577-3. Review. German.

PMID:
30350217
13.

The 8th edition AJCC/UICC TNM staging for p16-positive oropharyngeal carcinoma: is there space for improvement?

Sharma SJ, Wagner S, Reder HSF, Kroll T, Wuerdemann N, Klussmann JP, Wittekindt C.

Eur Arch Otorhinolaryngol. 2018 Dec;275(12):3087-3091. doi: 10.1007/s00405-018-5156-4. Epub 2018 Oct 16.

PMID:
30327906
14.

[HPV - A different view on Head and Neck Cancer].

Wittekindt C, Wagner S, Sharma SJ, Würdemann N, Knuth J, Reder H, Klußmann JP.

Laryngorhinootologie. 2018 Mar;97(S 01):S48-S113. doi: 10.1055/s-0043-121596. Epub 2018 Mar 22. Review. English, German.

15.

Development and external validation of nomograms in oropharyngeal cancer patients with known HPV-DNA status: a European Multicentre Study (OroGrams).

Grønhøj C, Jensen DH, Dehlendorff C, Marklund L, Wagner S, Mehanna H, Munck-Wikland E, Ramqvist T, Näsman A, Wittekindt C, Würdemann N, Sharma SJ, Gattenlöhner S, Kiss K, Andersen E, Spruce R, Batis N, Robinson M, Harrington K, Winter S, Jones TM, Klussmann JP, Dalianis T, Friborg J, von Buchwald C.

Br J Cancer. 2018 Jun;118(12):1672-1681. doi: 10.1038/s41416-018-0107-9. Epub 2018 May 24.

16.

Patient's perspective on long-term complications after superficial parotidectomy for benign lesions: Prospective analysis of a 2-year follow-up.

Wolber P, Volk GF, Horstmann L, Finkensieper M, Shabli S, Wittekindt C, Klussmann JP, Guntinas-Lichius O, Beutner D, Grosheva M.

Clin Otolaryngol. 2018 Mar 26. doi: 10.1111/coa.13104. [Epub ahead of print]

PMID:
29577637
17.

[The innate immune system in oropharyngeal squamous cell carcinoma : Immune modulation by HPV].

Wagner S, Böckmann H, Gattenlöhner S, Klussmann JP, Wittekindt C.

HNO. 2018 Apr;66(4):301-307. doi: 10.1007/s00106-018-0480-y. Review. German.

PMID:
29468275
18.

Rigid Triple Endoscopy Improves Clinical Staging of Primary Head and Neck Cancer.

Sharma SJ, Linke JJ, Kroll T, Wuerdemann N, Klussmann JP, Guntinas-Lichius O, Wittekindt C.

Oncol Res Treat. 2018;41(1-2):35-38. doi: 10.1159/000481173. Epub 2018 Jan 22.

19.

Reply to 'Comment on 'Human papillomavirus association is the most important predictor for surgically treated patients with oropharyngeal cancer".

Wagner S, Wittekindt C, Sharma SJ, Wuerdemann N, Jüttner T, Reuschenbach M, Prigge ES, von Knebel Doeberitz M, Gattenlöhner S, Burkhardt E, Pons-Kühnemann J, Klussmann JP.

Br J Cancer. 2018 Feb 6;118(3):e6. doi: 10.1038/bjc.2017.464. Epub 2018 Jan 23. No abstract available.

20.

Hypoxia-inducible factor-1α activation in HPV-positive head and neck squamous cell carcinoma cell lines.

Knuth J, Sharma SJ, Würdemann N, Holler C, Garvalov BK, Acker T, Wittekindt C, Wagner S, Klussmann JP.

Oncotarget. 2017 Sep 11;8(52):89681-89691. doi: 10.18632/oncotarget.20813. eCollection 2017 Oct 27.

21.

Intraindividual homogeneity of 18F-FDG PET/CT parameters in HPV-positive OPSCC.

Sharma SJ, Wittekindt C, Knuth J, Steiner D, Wuerdemann N, Laur M, Kroll T, Wagner S, Klussmann JP.

Oral Oncol. 2017 Oct;73:166-171. doi: 10.1016/j.oraloncology.2017.08.019. Epub 2017 Sep 14.

PMID:
28939071
22.

The role of high-risk human papillomavirus infections in laryngeal squamous cell carcinoma.

Wittekindt C, Wuerdemann N, Gattenlöhner S, Brobeil A, Wierzbicka M, Wagner S, Klußmann JP.

Eur Arch Otorhinolaryngol. 2017 Nov;274(11):3837-3842. doi: 10.1007/s00405-017-4718-1. Epub 2017 Aug 31. Review.

PMID:
28861601
23.

[Fibrinous lesions of the larynx in a 34-year old patient].

Wuerdemann N, Sharma SJ, Gattenlöhner S, Klußmann JP, Wittekindt C.

Laryngorhinootologie. 2017 Oct;96(10):710-713. doi: 10.1055/s-0043-116664. Epub 2017 Aug 23. German. No abstract available.

PMID:
28834976
24.

Prognostic Impact of AJCC/UICC 8th Edition New Staging Rules in Oropharyngeal Squamous Cell Carcinoma.

Würdemann N, Wagner S, Sharma SJ, Prigge ES, Reuschenbach M, Gattenlöhner S, Klussmann JP, Wittekindt C.

Front Oncol. 2017 Jun 30;7:129. doi: 10.3389/fonc.2017.00129. eCollection 2017.

25.

Risk Factors for Overall Survival Outcome in Surgically Treated Human Papillomavirus-Negative and Positive Patients with Oropharyngeal Cancer.

Wuerdemann N, Wittekindt C, Sharma SJ, Prigge ES, Reuschenbach M, Gattenlöhner S, Klussmann JP, Wagner S.

Oncol Res Treat. 2017;40(6):320-327. doi: 10.1159/000477097. Epub 2017 May 17.

26.

Human Papillomavirus-Related Head and Neck Cancer.

Wagner S, Sharma SJ, Wuerdemann N, Knuth J, Reder H, Wittekindt C, Klussmann JP.

Oncol Res Treat. 2017;40(6):334-340. doi: 10.1159/000477252. Epub 2017 May 19. Review.

27.

A two-arm multicenter phase II trial of one cycle chemoselection split-dose docetaxel, cisplatin and 5-fluorouracil (TPF) induction chemotherapy before two cycles of split TPF followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TISOC-1).

Inhestern J, Schmalenberg H, Dietz A, Rotter N, Maschmeyer G, Jungehülsing M, Grosse-Thie C, Kuhnt T, Görner M, Sudhoff H, Wittekindt C, Guntinas-Lichius O.

Ann Oncol. 2017 Aug 1;28(8):1917-1922. doi: 10.1093/annonc/mdx202.

PMID:
28498880
28.

Human papillomavirus association is the most important predictor for surgically treated patients with oropharyngeal cancer.

Wagner S, Wittekindt C, Sharma SJ, Wuerdemann N, Jüttner T, Reuschenbach M, Prigge ES, von Knebel Doeberitz M, Gattenlöhner S, Burkhardt E, Pons-Kühnemann J, Klussmann JP.

Br J Cancer. 2017 Jun 6;116(12):1604-1611. doi: 10.1038/bjc.2017.132. Epub 2017 May 4.

29.

Sensation loss after superficial parotidectomy: A prospective controlled multicenter trial.

Grosheva M, Shabli S, Volk GF, Sommer B, Ludwig L, Finkensieper M, Wittekindt C, Klussmann JP, Guntinas-Lichius O, Beutner D.

Head Neck. 2017 Mar;39(3):520-526. doi: 10.1002/hed.24647. Epub 2017 Jan 9.

PMID:
28067982
30.

Tumor Staging and HPV-Related Oropharyngeal Cancer.

Wittekindt C, Klussmann JP.

Recent Results Cancer Res. 2017;206:123-133. Review.

PMID:
27699534
31.

Frey's syndrome after superficial parotidectomy: role of the sternocleidomastoid muscle flap: a prospective nonrandomized controlled trial.

Grosheva M, Horstmann L, Volk GF, Holler C, Ludwig L, Weiß V, Finkensieper M, Wittekindt C, Klussmann JP, Guntinas-Lichius O, Beutner D.

Am J Surg. 2016 Oct;212(4):740-747.e1. doi: 10.1016/j.amjsurg.2016.01.020. Epub 2016 Mar 19.

PMID:
27083066
32.

Step-by-step protocol to perfuse and dissect the mouse parotid gland and isolation of high-quality RNA from murine and human parotid tissue.

Watermann C, Valerius KP, Wagner S, Wittekindt C, Klussmann JP, Baumgart-Vogt E, Karnati S.

Biotechniques. 2016 Apr 1;60(4):200-3. doi: 10.2144/000114404. eCollection 2016 Apr.

34.

[Human papillomavirus and squamous cell cancer of the head and neck region : Prognostic, therapeutic and prophylactic implications].

Reuschenbach M, Wagner S, Würdemann N, Sharma SJ, Prigge ES, Sauer M, Wittig A, Wittekindt C, von Knebel Doeberitz M, Klussmann JP.

HNO. 2016 Jul;64(7):450-9. doi: 10.1007/s00106-016-0123-0. Review. German.

PMID:
26864190
35.

CD56-positive lymphocyte infiltration in relation to human papillomavirus association and prognostic significance in oropharyngeal squamous cell carcinoma.

Wagner S, Wittekindt C, Reuschenbach M, Hennig B, Thevarajah M, Würdemann N, Prigge ES, von Knebel Doeberitz M, Dreyer T, Gattenlöhner S, Klussmann JP.

Int J Cancer. 2016 May 1;138(9):2263-73. doi: 10.1002/ijc.29962. Epub 2016 Jan 8.

36.

Cone beam computed tomography (CBCT) sialography--an adjunct to salivary gland ultrasonography in the evaluation of recurrent salivary gland swelling.

Kroll T, May A, Wittekindt C, Kähling C, Sharma SJ, Howaldt HP, Klussmann JP, Streckbein P.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2015 Dec;120(6):771-5. doi: 10.1016/j.oooo.2015.09.005. Epub 2015 Sep 14.

PMID:
26548729
37.

[HPV-associated head and neck cancer : mutational signature and genomic aberrations].

Wagner S, Würdemann N, Hübbers C, Reuschenbach M, Prigge ES, Wichmann G, Hess J, Dietz A, Dürst M, Tinhofer I, von Knebel-Döberitz M, Wittekindt C, Klussmann JP.

HNO. 2015 Nov;63(11):758-67. doi: 10.1007/s00106-015-0074-x. German.

PMID:
26507715
38.

[Pre-auricular mass in a 38-year-old patient].

Wuerdemann N, Sharma SJ, Kroll T, Streckbein P, Dreyer T, Gattenlöhner S, Wittekindt C, Klußmann JP.

Laryngorhinootologie. 2015 Dec;94(12):843-5. doi: 10.1055/s-0035-1559691. Epub 2015 Oct 15. German. No abstract available.

PMID:
26468671
39.

Voice and respiratory outcomes after permanent transoral surgery of bilateral vocal fold paralysis.

Nawka T, Sittel C, Arens C, Lang-Roth R, Wittekindt C, Hagen R, Mueller AH, Nasr AI, Guntinas-Lichius O, Friedrich G, Gugatschka M.

Laryngoscope. 2015 Dec;125(12):2749-55. doi: 10.1002/lary.25415. Epub 2015 Aug 1.

PMID:
26235099
40.

Prognostic Role of Circulating Tumor Cells during Induction Chemotherapy Followed by Curative Surgery Combined with Postoperative Radiotherapy in Patients with Locally Advanced Oral and Oropharyngeal Squamous Cell Cancer.

Inhestern J, Oertel K, Stemmann V, Schmalenberg H, Dietz A, Rotter N, Veit J, Görner M, Sudhoff H, Junghanß C, Wittekindt C, Pachmann K, Guntinas-Lichius O.

PLoS One. 2015 Jul 17;10(7):e0132901. doi: 10.1371/journal.pone.0132901. eCollection 2015.

41.

[Spontaneous bone regeneration following ceratocystic odontogenic tumor].

Kroll T, Streckbein P, Kähling C, Wittekindt C, Sharma SJ, Klußmann JP, Litzlbauer D.

HNO. 2016 Jan;64(1):49-52. doi: 10.1007/s00106-015-0038-1. German.

PMID:
26169211
42.

[Panendoscopy].

Kroll T, Streckbein P, Sharma SJ, Wittekindt C, Klußmann JP.

Laryngorhinootologie. 2015 Jul;94(7):434-5. doi: 10.1055/s-0035-1555632. Epub 2015 Jul 6. German. No abstract available.

PMID:
26147586
43.

Increased sensitivity of HPV-positive head and neck cancer cell lines to x-irradiation ± Cisplatin due to decreased expression of E6 and E7 oncoproteins and enhanced apoptosis.

Ziemann F, Arenz A, Preising S, Wittekindt C, Klussmann JP, Engenhart-Cabillic R, Wittig A.

Am J Cancer Res. 2015 Feb 15;5(3):1017-31. eCollection 2015.

44.

[Sialendoscopy].

Kroll T, Sharma SJ, Kähling C, Wittekindt C, Klußmann JP, Streckbein P.

Laryngorhinootologie. 2015 May;94(5):292-293. doi: 10.1055/s-0035-1549388. Epub 2015 May 7. German. No abstract available.

PMID:
25951444
45.

[Surgical Simulation Models for Sialendoscopy].

Geisthoff U, Volk GF, Finkensieper M, Wittekindt C, Guntinas-Lichius O.

Laryngorhinootologie. 2015 Sep;94(9):587-95. doi: 10.1055/s-0034-1395660. Epub 2015 Mar 4. German.

PMID:
25739071
46.

Permanent transoral surgery of bilateral vocal fold paralysis: a prospective multi-center trial.

Nawka T, Sittel C, Gugatschka M, Arens C, Lang-Roth R, Wittekindt C, Hagen R, Müller AH, Volk GF, Guntinas-Lichius O.

Laryngoscope. 2015 Jun;125(6):1401-8. doi: 10.1002/lary.25137. Epub 2015 Jan 30.

PMID:
25643933
47.

Compound lesion of a basal cell carcinoma and a malignant melanoma: is there a common genetic origin?

Sharma SJ, Kreisel M, Holler C, Kroll T, Gamerdinger U, Gattenloehner S, Klussmann JP, Wittekindt C.

Eur Arch Otorhinolaryngol. 2015 Feb;272(2):505-9. doi: 10.1007/s00405-014-3318-6. Epub 2014 Oct 9. No abstract available.

PMID:
25297533
48.

No evidence of oncogenic KRAS mutations in squamous cell carcinomas of the anogenital tract and head and neck region independent of human papillomavirus and p16(INK4a) status.

Prigge ES, Urban K, Stiegler S, Müller M, Kloor M, Mai S, Ottstadt M, Lohr F, Wenz F, Wagner S, Wittekindt C, Klussmann JP, Hampl M, von Knebel Doeberitz M, Reuschenbach M.

Hum Pathol. 2014 Nov;45(11):2347-54. doi: 10.1016/j.humpath.2014.08.001. Epub 2014 Aug 23.

PMID:
25257576
49.

Updated S2K AWMF guideline for the diagnosis and follow-up of obstructive sialadenitis--relevance for radiologic imaging.

Vogl TJ, Al-Nawas B, Beutner D, Geisthoff U, Gutinas-Lichius O, Naujoks C, Reich R, Schröder U, Sproll C, Teymoortash A, Ußmüller J, Wittekindt C, Zenk J, Fischer S.

Rofo. 2014 Sep;186(9):843-6. doi: 10.1055/s-0034-1366867. Epub 2014 Aug 15.

50.

p16(INK4a) /Ki-67 co-expression specifically identifies transformed cells in the head and neck region.

Prigge ES, Toth C, Dyckhoff G, Wagner S, Müller F, Wittekindt C, Freier K, Plinkert P, Hoffmann J, Vinokurova S, Klussmann JP, von Knebel Doeberitz M, Reuschenbach M.

Int J Cancer. 2015 Apr 1;136(7):1589-99. doi: 10.1002/ijc.29130. Epub 2014 Aug 19.

Supplemental Content

Loading ...
Support Center